Cart 0
Compare 0 Wishlist 0
My Account
Menu

<h1>Speciality Medicines</h1>

Anemol Infusion
0
In stock
Model: MRM_102020
₹303
Neomol 170mg Suppository
0
In stock
Model: MRM_102817
₹57
MOL IV 1000mg Injection
0
In stock
Model: MRM_201609
₹237
Paraprime Injection
0
In stock
Model: MRM_102968
₹189
Dolo 1000mg Infusion
0
In stock
Model: MRM_100524
₹249
Neomol Injection
0
In stock
Model: MRM_102821
₹548
Neomol 80mg Injection
0
In stock
Model: MRM_102820
₹41
Neomol 250mg Suppository
0
In stock
Model: MRM_102818
₹134
MOL Plus Injection
0
In stock
Model: MRM_201610
₹452
Malidens 1000mg Injection
0
In stock
Model: MRM_102666
₹228
Varmol Infusion 100ml
0
In stock
Model: MRM_201154
₹303
Pazitop 1000mg Infusion
0
In stock
Model: MRM_201141
₹266
Prolop Infusion 100ml
0
In stock
Model: MRM_200616
₹162
Molshil 60mg Oral Disintegrating Strips
0
In stock
Model: MRM_201217
₹99
Calpol Paediatric Drops
0
In stock
Model: MRM_92392
₹39
Parahenz Injection
0
In stock
Model: MRM_102967
₹396
Neomol 300mg Injection
0
In stock
Model: MRM_102819
₹9
Molshil 120mg Oral Disintegrating Strips
0
In stock
Model: MRM_201216
₹165
Calpol 120mg Suspension
0
In stock
Model: MRM_92389
₹51
Speciality Medicines are pharmaceutical products designed to treat complex health conditions that require precise medical intervention. They are formulated to meet the specific needs of patients with chronic illnesses, rare diseases, or those needing highly targeted therapies. These medicines often undergo rigorous clinical trials to ensure their efficacy and safety.

Understanding Speciality Medicines

  • Require precise medical intervention
  • Formulated to meet specific patient needs
  • Undergo rigorous clinical trials

Key Features

  • Targeted treatment for complex health conditions
  • High level of efficacy and safety
  • Often used for chronic illnesses and rare diseases

Benefits

  • Improved patient outcomes
  • Enhanced quality of life for patients
  • Tailored approach to treatment

Challenges

  • Higher cost compared to generic medications
  • Limited availability in some regions
  • Complex regulatory processes for approval